203 related articles for article (PubMed ID: 9683887)
1. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
Barbaud A; Simon M; Parache RM; Serre G
Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
[TBL] [Abstract][Full Text] [Related]
2. [Specific characteristics of skin basal cell carcinoma invasion].
Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
[TBL] [Abstract][Full Text] [Related]
3. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
4. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
5. Comparative morphometric analysis of primary versus recurrent basal cell carcinoma and of histological subtypes. Significance of morphometry of the nuclei.
Bierhoff E; Appel K; Appel T; Buettner R; Wardelmann E
Anticancer Res; 2003; 23(3B):2697-700. PubMed ID: 12894560
[TBL] [Abstract][Full Text] [Related]
6. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
8. The expression of p63 in basal cell carcinomas and association with histological differentiation.
Bircan S; Candir O; Kapucoglu N; Baspinar S
J Cutan Pathol; 2006 Apr; 33(4):293-8. PubMed ID: 16630179
[TBL] [Abstract][Full Text] [Related]
9. The detection of basal cell determinants in human basal cell carcinomas using two different monoclonal antibodies.
Habets JM; Tank B; Vuzevski VD; van Reede EC; Stolz E; van Joost T
Acta Derm Venereol; 1987; 67(5):391-8. PubMed ID: 2448989
[TBL] [Abstract][Full Text] [Related]
10. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
[TBL] [Abstract][Full Text] [Related]
11. Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma.
Habets JM; Tank B; Vuzevski VD; Brevé J; Stolz E; van Joost T
Anticancer Res; 1988; 8(4):611-6. PubMed ID: 2460019
[TBL] [Abstract][Full Text] [Related]
12. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
13. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
14. Immunoelectron microscopic studies on cytokeratins in human basal cell carcinoma.
Habets JM; Tank B; Vuzevski VD; Brevé J; Van der Kwast T; Van Joost T
Anticancer Res; 1989; 9(1):65-70. PubMed ID: 2468307
[TBL] [Abstract][Full Text] [Related]
15. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
16. Correlation between histologic findings on punch biopsy specimens and subsequent excision specimens in recurrent basal cell carcinoma.
Mosterd K; Thissen MR; van Marion AM; Nelemans PJ; Lohman BG; Steijlen PM; Kelleners-Smeets NW
J Am Acad Dermatol; 2011 Feb; 64(2):323-7. PubMed ID: 21238826
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin expression in trichilemmal carcinoma suggests differentiation towards follicular infundibulum.
Kurokawa I; Senba Y; Nishimura K; Habe K; Hakamada A; Isoda K; Yamanaka K; Mizutani H; Tsubura A
In Vivo; 2006; 20(5):583-5. PubMed ID: 17091763
[TBL] [Abstract][Full Text] [Related]
18. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas.
Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I
J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin profile in basal cell carcinoma.
Alessi E; Venegoni L; Fanoni D; Berti E
Am J Dermatopathol; 2008 Jun; 30(3):249-55. PubMed ID: 18496426
[TBL] [Abstract][Full Text] [Related]
20. [Depth of invasion of basaliomas].
Breuninger H; Flad P; Rassner G
Z Hautkr; 1989 Mar; 64(3):191-6. PubMed ID: 2718551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]